Adaptive Biotechnologies (ADPT) EPS (Diluted) Growth (3y) (2023 - 2026)
Adaptive Biotechnologies (ADPT) EPS (Diluted) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 10.87% |
| 10 | Adaptive Biotechnologies | 3.70 Bn | 3.48 Bn | 52.17 Mn | 5.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36% |
| Dec 31, 2025 | 29.61% |
| Sep 30, 2025 | 29.49% |
| Jun 30, 2025 | -20.35% |
| Mar 31, 2025 | 48.55% |
| Dec 31, 2024 | 22.71% |
| Sep 30, 2024 | 51.83% |
| Jun 30, 2024 | 49.90% |
| Mar 31, 2024 | 50.58% |
| Dec 31, 2023 | -12.31% |